Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jang, Hyeon-Lok | - |
dc.contributor.author | El-Gamal, Mohammed I. | - |
dc.contributor.author | Choi, Hye-Eun | - |
dc.contributor.author | Choi, Ho-Yeong | - |
dc.contributor.author | Lee, Kyung-Tae | - |
dc.contributor.author | Oh, Chang-Hyun | - |
dc.date.accessioned | 2024-01-20T10:33:39Z | - |
dc.date.available | 2024-01-20T10:33:39Z | - |
dc.date.created | 2022-01-10 | - |
dc.date.issued | 2014-01-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/127219 | - |
dc.description.abstract | The regulations of NO and PGE(2) productions are research topics of interest in the field of antiinflammatory drug development. In the present study, a series of tricyclic fused coumarin sulfonate derivatives was synthesized and evaluated for their abilities to inhibit NO and PGE(2) productions in LPS-induced RAW 264.7 macrophages. Among all the target compounds, compound 1g possessing p-(trifluoromethyl) phenyl and fused cycloheptane moieties showed the highest inhibitory effects on NO and PGE2 productions. Compound 1g not only inhibited COX-2 activity but also reduced expressions of COX-2 and iNOS. Furthermore, ADME profiling showed that compounds 1g, 1j, 1m, and 1n are estimated to be orally bioavailable. (C) 2013 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | Pergamon Press Ltd. | - |
dc.subject | INFLAMMATION | - |
dc.title | Synthesis of tricyclic fused coumarin sulfonates and their inhibitory effects on LPS-induced nitric oxide and PGE(2) productions in RAW 264.7 macrophages | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmcl.2013.12.018 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, v.24, no.2, pp.571 - 575 | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.volume | 24 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 571 | - |
dc.citation.endPage | 575 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000329430600032 | - |
dc.identifier.scopusid | 2-s2.0-84891890612 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordAuthor | Antiinflammatory | - |
dc.subject.keywordAuthor | Coumarin | - |
dc.subject.keywordAuthor | Nitric oxide | - |
dc.subject.keywordAuthor | PGE(2) | - |
dc.subject.keywordAuthor | Sulfonate | - |
dc.subject.keywordAuthor | Tricyclic fused coumarin | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.